Dasabuvir: An FDA-approved drug inhibiting poxvirus transmission by targeting both migrasome formation and extracellular enveloped virus production

J Infect. 2025 Jan 2:106403. doi: 10.1016/j.jinf.2024.106403. Online ahead of print.
No abstract available

Publication types

  • Letter